PTGX
Protagonist Therapeutics, Inc
NASDAQ · Healthcare · Biotechnology · US
$134.44
+4.42%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.49x
- Debt / assets
- 0.01x
- Debt / EBITDA
- 0.11x
- Net debt / EBITDA
- -4.78x
Liquidity & coverage
- Current ratio
- 21.71x
- Quick ratio
- 21.71x
- Cash ratio
- 21.05x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $770.0M
Cash & dividend
- FCF / debt
- 14.34x
- Cash flow / debt
- 14.24x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026